β-Nicotinamide mononucleotide

We are β-Nicotinamide mononucleotide CAS:1094-61-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:β-Nicotinamide mononucleotide
CAS.NO:1094-61-7
Synonyms:β-Nicotinamide mononucleotide
NMN zwitterion
NMN
Beta-Nicotinamide Mononucleotide
Nicotinamide D-ribonucleotide
 
Physical and Chemical Properties:
Molecular Formula C11H15N2O8P
Molecular Weight 334.219
Storage condition 2-8°C
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer 
 
requirements
Storage:Store in a cool, ventilated place
Application: Targeting anti-aging and repairing cells.

β-Nicotinamide mononucleotide


Related News: ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses.Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.69045-82-5 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.4-Trifluoromethylbenzoylchloride Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
butyl carbitol Cas:112-34-5 View Details
4-Hexyl-1,3-benzenediol View Details
2,4-Dichloro-5-methoxypyrimidine Cas:19646-07-2 View Details
2,3-Dichloro-6-methoxyquinoxaline Cas:39267-04-4 manufacturer 1-Adamantane Methanol Cas:770-71-8 manufacturer 3-Bromo-4-fluoronitrobenzene manufacturer BPC-48 / BPC-36 Cas:15990-43-9/ 68133-60-8 manufacturer cyclohexanecarboxaldehyde Cas:2043-61-0 manufacturer